Mostrar el registro sencillo del ítem

Terapia asistida por plantas para el tratamiento de los trastornos por uso de sustancias parte 2 : más allá de los límites borrosos.

dc.contributor.authorPolit, Matteospa
dc.contributor.authorFriso, Fabiospa
dc.contributor.authorMabit, Jacquesspa
dc.date.accessioned2019-07-01 00:00:00
dc.date.accessioned2020-12-09T16:49:09Z
dc.date.available2019-07-01 00:00:00
dc.date.available2020-12-09T16:49:09Z
dc.date.issued2019-07-01
dc.identifier.issn0122-8455
dc.identifier.urihttps://doi.org/10.17151/culdr.2019.24.28.2.
dc.identifier.urihttps://repositorio.ucaldas.edu.co/handle/ucaldas/12777
dc.description.abstractObjetivo. Este artículo pretende ofrecer una visión de los centros a nivel global que utilizan derivados de plantas o animales para el tratamiento de trastornos por uso de sustancias y ofrecer una reflexión sobre el concepto de drogas como agentes medicinales o tóxicos según el contexto de uso, cultura y política. Metodología. Hemos considerado algunas prácticas provenientes de África, Asia, Europa y las Américas, realizando una investigación basada en literatura científica, intercambio de información con centros de tratamiento, búsquedas en Internet y la experiencia personal de los autores. Resultados y discusión. Se describen diferentes casos de uso de medicinas naturales, incluyendo derivados psicoactivos de la Tabernanthe iboga y Bufo alvarius. Conclusiones. Las fronteras borrosas entre considerar el consumo de drogas como un crimen o un problema de salud podrían superarse inspirándose en la antigua sabiduría de las medicinas tradicionales.spa
dc.description.abstractObjective. This article aims to offer a vision of the centers at a global level that use derivatives of plants or animals for the treatment of substance use disorders, and to offer a reflection on the concept of drugs as medicinal or toxicant agents depending on the context of use, culture and policy. Methodology. Some practices coming from Africa, Asia, Europe and the Americas were considered, carrying out a research based on scientific literature, exchange of information with treatment centers, internet search and the personal experience of the authors. Results and Discussion. Different cases of the use of natural medicines are described including psychoactive derivatives of Tabernanthe iboga and Bufo alvarius. Conclusions. The blurred boundaries between considering drug consumption as a crime or as a health issue could be overcome by being inspired by the ancient wisdom of traditional medicines.eng
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherUniversidad de Caldasspa
dc.rightsDerechos de autor 2019 Matteo Politeng
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0eng
dc.sourcehttps://revistasojs.ucaldas.edu.co/index.php/culturaydroga/article/view/173eng
dc.subjectdrug addictioneng
dc.subjectplant-assisted therapyeng
dc.subjectsubstance use disorders (SUDs)eng
dc.subjecttraditional and complementary medicineseng
dc.subjectdrogadicciónspa
dc.subjectterapia asistida por plantasspa
dc.subjecttrastornos por uso de sustancias (TUS)spa
dc.subjectmedicinas tradicionales y complementariasspa
dc.titleTerapia asistida por plantas para el tratamiento de los trastornos por uso de sustancias parte 2 : más allá de los límites borrosos.spa
dc.typeSección Producción científica e intelectualspa
dc.typeArtículo de revistaspa
dc.typeJournal Articleeng
dc.identifier.doi10.17151/culdr.2019.24.28.2.
dc.identifier.eissn2590-7840
dc.relation.citationendpage42
dc.relation.citationissue28spa
dc.relation.citationstartpage19
dc.relation.citationvolume24spa
dc.relation.ispartofjournalCultura y Drogaspa
dc.relation.referencesAldhous, P. (2005). Drug rehabilitation: Cold turkey, Vietnamese style. Nature, 433 (7026), 568–569.eng
dc.relation.referencesAleem, Z. (2018). 14 years after decriminalizing all drugs, here’s what Portugal looks like. Recovered from https://mic.com/articles/110344/14-years-afterportugal-decriminalized-all-drugs-here-s-what-shappening#.mhCFjMGkf.eng
dc.relation.referencesAlmendro, M. & López, E. (2016). Beyond Frontiers: Meditative Practice, Clinical Practice and Scientific Research. J Psychol Psychother, 6, 281.eng
dc.relation.referencesConselho Estadual de Políticas Sobre Drogas. (2016). 126 (8), Seção I quintafeira. São Paulo: Diário Oficial Poder Executivo. Recovered from https://www.ibogainealliance.org/wp-content/uploads/2016/01/CONSELHO-ESTADUALDE-POL%C3%8DTICAS-SOBRE-DROGAS.pdf.eng
dc.relation.referencesBabor, T., Caulkins, J., Edwards, G., Fischer, B., Foxcroft, D. & Humphreys, K. (2010). Drug policy and the public good. New York: Oxford University Press.eng
dc.relation.referencesBenfer, I., Zahnow, R., Barratt, M., Maier, L., Winstock, A. & Ferris, J. (2018). The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries. International Journal of Drug Policy, 56, 162–75.eng
dc.relation.referencesBradford, A. C., Bradford, D., Abraham, A. J. & Bagwell Adams, G. (2018). Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. JAMA Intern Med, 178 (5), 667-72.eng
dc.relation.referencesBogenschutz, M. P. & Ross, S. (2018). Therapeutic Applications of Classic Hallucinogens. Current topics in behavioral neurosciences, 36, 361-391.eng
dc.relation.referencesBouso Saiz, J, C. (2012). Personalidad, Psicopatología y rendimiento neuropsicológico de los consumidores rituales de ayahuasca (tesis doctoral). Universitat Autónoma de Barcelona, Barcelona, España.eng
dc.relation.referencesBridgeman, M. B. & Abazia, D. T. (2017). Medicinal Cannabis: History, Pharmacology, and Implications for the Acute Care Setting. Pharmacology & Therapeutics, 42 (3), 180-8.eng
dc.relation.referencesBrave, P. S., Bruins, E. & Bronkhorst, M. W. (2014). Phyllomedusa bicolor skin secretion and the Kambô ritual. The journal of venomous animals and toxins including tropical diseases, 20, (40).eng
dc.relation.referencesDhawan, K. (2003). Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.-a brief perspective. Addict Biol, 8, 379-86.eng
dc.relation.referencesDhawan, K., Kumar, S. & Sharma, A. (2002). Suppression of alcohol-cessationoriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linneaus in mice. J Ethnopharmacol, 81, 239-44.eng
dc.relation.referencesFernandez, J. W. (1982). Bwiti: An Ethnography of The Religious Imagination in Africa. Princeton: Princeton University Press.eng
dc.relation.referencesFerreira, S. (2017). Portugal’s radical drugs policy is working. Why hasn’t the world copied it?. Recovered from https://www.theguardian.com/news/2017/dec/05/portugals-radical-drugs-policy-is-working-why-hasnt-the-world-copied-it.eng
dc.relation.referencesFrecska, E., Bokor, P. & Winkelman, M. (2016). The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Front. Pharmacol, 7 (35).eng
dc.relation.referencesGarland, E. L. & Howard, M. O. (2018). Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research. Addict Sci Clin Pract, 13 (1), 14.eng
dc.relation.referencesGorman, P. (1993). Making Magic. Recovered from http://www.artoftransformations.com/files/Making-Magic-by-Peter-Gorman.pdf.eng
dc.relation.referencesGrant, S., Kandrack, R., Motala, A., Shanman, R., Booth, M., Miles, J., Sorbero,eng
dc.relation.referencesM…,. & Hempel, S. (2016). Acupuncture for substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend, 163,1-15.eng
dc.relation.referencesHabib, G. & Artul, S. (2018). Medical Cannabis for the Treatment of Fibromyalgia. Journal of Clinical Rheumatology, 24 (5), 255–258.eng
dc.relation.referencesHeggenhougen, H. K. (1984). Traditional medicine and the treatment of drug addicts: three examples from Southeast Asia. Medical Anthropology Quarterly, 16 (1), 3-7.eng
dc.relation.referencesHinojosa, O. R. (2017). OTAC: Toad Medicine and its Role in Modern World. Paper presented at the International Transpersonal Conference, Prague.eng
dc.relation.referencesHohmann, L., Bradt, J., Stegemann, T. & Koelsch, S. (2017). Effects of music therapy and music-based interventions in the treatment of substance use disorders: A systematic review. PLoS One, 12 (11).eng
dc.relation.referencesICEERS. (2017). Risks associated with combining Bufo Alvarius with ayahuasca. International Center for Ethnobotanical Education Research and Service. Recovered from http://news.iceers.org/2017/05/alert-bufo-alvarius-andayahuasca/.eng
dc.relation.referencesLabate, B. & Cavnar, C. (2018). The Expanding World Ayahuasca Diaspora: Appropriation, Integration and Legislation. London: Routledge.eng
dc.relation.referencesLabate, B. & Coffaci de Lima, E. (2014). Medical Drug or Shamanic Power Plant: The Uses of Kambô in Brazil. Ponto Urbe [Online], 15. DOI: 10.4000/pontourbe.2384.eng
dc.relation.referencesLevinson, J. (2018). Opioid addicts are turning to a clinic in Mexico to break their addiction, but there’s a catch. GlobalPost. Recovered from https://www.pri.org/stories/2018-03-06/opioid-addicts-are-turning-clinic-mexico-break-theiraddiction-theres-catch.eng
dc.relation.referencesLlagostera, A., Torres, M. C. & Costa, M. A. (1988). El complejo psicotrópico en Scolor-3 (San Pedro de Atacama). Estudios Atacámenos, 9, 61-98.eng
dc.relation.referencesLu, L., Liu, Y., Zhu, W., Shi, J., Liu, Y., Ling, W. & Kosten, T. R. (2009). Traditional medicine in the treatment of drug addiction. American Journal of Drug and Alcohol Abuse, 35, 1-11.eng
dc.relation.referencesLukas, S. E., Penetar, D., Berko, J., Vicens, L., Palmer, C., Mallya, G., Macklin, E. A. & Lee D. Y. (2005). An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcoholism Clinical and Experimental Research, 29 (5), 756-62.eng
dc.relation.referencesLuna, L. E. (1984). The Concept of Plants as Teachers Among Four Mestizo Shamans of Iquitos, Northeast Peru. Journal of Ethnopharmacology, 11, 135-156.eng
dc.relation.referencesMabit, J. (1993). Adicción y shamanismo budista - El monasterio de las cuevas delbambú. Revista Takiwasi, 2, 57-78eng
dc.relation.referencesMabit, J. (2002). Interview de Jacques Mabit par Evelyne Sarah Mercier. Paris, France: ES Mercier.eng
dc.relation.referencesMabit, J. (2007). Ayahuasca in the treatment of addictions. M. J. Winkelman. & T. B. Roberts. (Eds), Psychedelic Medicine New Evidence for Hallucinogenic Substances as Treatments (pp. 87–103). Westport, CT: Praeger Publishers.eng
dc.relation.referencesMabit, J. & González, J. (2013). Hacia una medicina transcultural. Reflexiones y propuestas a partir de la experiencia en Takiwasi. Journal of Transpersonal Research, 5 (2), 49-76.eng
dc.relation.referencesManyam, B. V., Dhanasekaran, M. & Hare, T. A. (2004). Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytother Res, 18, 706-12.eng
dc.relation.referencesMcGown, J. (2006). Out of Africa: Mysteries of Access and Benefit Sharing. Richmond, South Africa: African Centre for Biosafety.eng
dc.relation.referencesMedsafe. (2009). Minutes of the 42nd Meeting of the Medicines Classification Committee. Recovered from http://www.medsafe.govt.nz/profs/class/Agendas/agen42.htm.eng
dc.relation.referencesMeletis, C. D. & Zabriskie, N. (2008). Natural Approaches to Treating Addiction. Alternative and Complementary Therapies, 14 (6), 275-81.eng
dc.relation.referencesMerica, D. (2017). Trump declares opioid epidemic a national public health emergency. Recovered from https://edition.cnn.com/2017/10/26/politics/donaldtrump-opioid-epidemic/index.html.eng
dc.relation.referencesMorel, L. J., Giros, B. & Daugé, V. (2009). Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats. Neuropsychopharmacology, 34 (11), 2469-76.eng
dc.relation.referencesNaranjo, C. (1969). Psychotherapeutic possibilities of new fantasy-enhancing drugs. Clinical Toxicology, 2, 209-24.eng
dc.relation.referencesNaranjo, P. (1986). El Ayahuasca en la arqueología ecuatoriana. América Indígena, 46 (1), 117-127.eng
dc.relation.referencesNencini, P. (2002). The shaman and the rave party: social pharmacology of ecstasy. Substance Use & Misuse, 37 (8-10), 923-39.eng
dc.relation.referencesNoller, G. E., Frampton, C. M., & Yazar-Klosinski, B. (2018). Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American Journal of Drug and Alcohol Abuse, 44 (1), 37-46.eng
dc.relation.referencesOgalde, J. P., Arriaza, B. T. & Soto, E. C. (2009). Identification of psychoactive alkaloids in ancient Andean human hair by gas chromatography/massspectrometry. Journal of Archaeological Science, 36 (2), 467-72.eng
dc.relation.referencesPaskulin, R., Jamnik, P., Živin, M., Raspor, P. & Štrukelj, B. (2006). Ibogaine affects brain energy metabolism. European Journal of Pharmacology, 15 (552), 11-4.eng
dc.relation.referencesPenetar, D. M., Toto, L. H., Lee, D. Y. & Lukas, S. E. (2015). A Single Dose of Kudzu Extract Reduces Alcohol Consumption in a Binge Drinking Paradigm. Drug Alcohol Depend, 153,194-200.eng
dc.relation.referencesPoliti, M. (2018). Healing and Knowledge with Amazonian Shamanic Diet. Psychedelic Plant Medicine. Recovered from https://chacruna.net/healingknowledge-amazonian-shamanic-diet/.eng
dc.relation.referencesPoliti, M., Friso, F. & Mabit, J. (2018). Plant based assisted therapy for the treatment of substance use disorders - part 1. The case of Takiwasi Center and other similar experiences. Revista Cultura y Droga, 23 (26), 99-126. DOI: 10.17151/culdr.2018.23.26.7.eng
dc.relation.referencesReiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6 (35).eng
dc.relation.referencesRomanoff, S. (2004). El uso de la medicina del sapo. In S. Romanoff (Ed), Matsesën Nampid Chuibanaid. La vida tradicional de los Matsés (pp. 120-122). Lima, Perú: CAAAP.eng
dc.relation.referencesSarkar, S. & Varshney, M. (2017). Yoga and substance use disorders: A narrative review. Asian J Psychiatr, 25,191-6.eng
dc.relation.referencesSarris, J., Stough, C., Bousman, C. A., Wahid, Z. T., Murray, G., Teschke, R., Savage, KM…,. Schweitzer, I. (2013). Kava in the treatment of generalized anxiety disorder: A double-blind, randomized, placebo-controlled study. J ClinPsychopharmacol, 33 (5), 643-8.eng
dc.relation.referencesSchenberg, E. E., Comis, M. A., Chaves, B. R. & Silveira, D. X. (2014). Treating drug dependence with the aid of ibogaine: A retrospective study. Journal of Psychopharmacology, 28 (11), 993-1000.eng
dc.relation.referencesSchep, L., Slaughter R., Galea, S. & Newcombe, D. (2016). Ibogaine for treating drug dependence. What is a safe dose? Drug and Alcohol Dependence, 166 (1), 1-5.eng
dc.relation.referencesSen, S. & Chakraborty, R. (2017). Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: importance, challenges and future. Journal of Traditional and Complementary Medicine, 7 (2), 234-244.eng
dc.relation.referencesSilva, J. (2017). Fighting addiction at a Thai monastery. Recovered from https://www.reuters.com/article/thailand-drugs-temple-int-idUSKBN18617D.eng
dc.relation.referencesSteiner, G. G. (2001). Kava as an anticraving agent: Preliminary data. Pac Health Dialog, 8, 335-9.eng
dc.relation.referencesTalin, P. & Sanabria, E. (2017). Ayahuasca’s entwined efficacy: An ethnographic study of ritual healing from “addiction”. The International Journal on Drug Policy, 44, 23-30.eng
dc.relation.referencesTerburg, D., Syal, S., Rosenberg, L. A., Heany, S., Phillips, N., Gericke, N., Stein, D. J. & Van Honk, J. (2013). Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology, 38 (13), 2708-16.eng
dc.relation.referencesThomas, K., Malcolm, B. & Lastra, D. (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Journal of Psychoactive Drugs, 49 (5), 446-455.eng
dc.relation.referencesUjváry, I. (2014). Psychoactive natural products: overview of recent developments. Ann Ist Super Sanità, 50 (1), 12-27.eng
dc.relation.referencesWalsh, Z., Gonzalez, R., Crosby, K. S., Thiessen, M., Carroll, C. & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51,15-29.eng
dc.relation.referencesWen, H. & Hockenberry, J. M. (2018). Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees. JAMA Intern Med, 178 (5), 673-9.eng
dc.relation.referencesWHO. (2016). Management of substance abuse: cannabis. World Health Organization. Recovered from www.who.int/substance_abuse/facts/cannabis/en.2016.eng
dc.relation.referencesWinkelman, M. (2014). Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. Curr Drug Abuse Rev, 7 (2),101-16.eng
dc.relation.referencesYarnell, E. & Abascal, K. (2001). Botanical Remedies for Nicotine Addiction. Alternative and Complementary Therapies, 7 (6), 337-40.eng
dc.relation.referencesZhu, W., Zhang, Y., Huang, Y. & Lu, L. (2017). Chinese Herbal Medicine for the Treatment of Drug Addiction. Int Rev Neurobiol, 135, 279-95.eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesseng
dc.rights.creativecommonsEsta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0.eng
dc.title.translatedPlant based assisted therapy for the treatment of substance use disorders part 2 : beyond blurred boundaries.eng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501eng
dc.type.contentTexteng
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersioneng
dc.relation.citationeditionNúm. 28 , Año 2019 : Julio - Diciembrespa
dc.relation.bitstreamhttps://revistasojs.ucaldas.edu.co/index.php/culturaydroga/article/download/173/134
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85eng
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2eng


Ficheros en el ítem

FicherosTamañoFormatoVer
culturaydroga-173.pdf398.4Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Derechos de autor 2019 Matteo Polit
Excepto si se señala otra cosa, la licencia del ítem se describe como Derechos de autor 2019 Matteo Polit